• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高流量鼻导管通气与标准氧疗在急性呼吸衰竭无创通气间歇期的应用比较:一项前瞻性随机对照试验

High-flow nasal therapy vs standard oxygen during breaks off noninvasive ventilation for acute respiratory failure: A pilot randomized controlled trial.

机构信息

Pulmonary, Critical Care and Sleep Medicine Division, Tufts Medical Center, Boston, MA, USA.

Tufts Clinical and Translational Science Institute, Tufts University, Boston, MA, USA; The Institute for Clinical Research and Health Policy Study, Tufts Medical Center, Boston, MA, USA.

出版信息

J Crit Care. 2018 Dec;48:418-425. doi: 10.1016/j.jcrc.2018.10.004. Epub 2018 Oct 5.

DOI:10.1016/j.jcrc.2018.10.004
PMID:30321833
Abstract

PURPOSE

To assess the role of high-flow nasal therapy (HFNT) compared to standard oxygen (SO) as complementary therapy to non-invasive ventilation (NIV).

METHODS

Multicenter trial including patients (n = 54) anticipated to receive NIV for ≥24 h due to acute or acute-on-chronic respiratory failure. Subjects were randomized (1:1) to SO or HFNT during breaks off NIV. Primary outcome was total time on and off NIV. Secondary outcomes were comfort and dyspnea, respiratory rate (RR), oxygen saturation (SO), tolerance and side effects.

RESULTS

Total time per patient on NIV (1315 vs 1441 min) and breaks (1362 vs 1196 min), and mean duration of each break (520 vs 370 min) were similar in the HFNT and SO arms (p > .05). Comfort score was higher on HFNT than on SO (8.3 ± 2.7 vs 6.9 ± 2.3, p = .001). Dyspnea, RR and SO were similar in the two arms, but the increase in RR and dyspnea seen with SO during breaks did not occur with HFNT.

CONCLUSION

Compared to SO, HFNT did not reduce time on NIV. However, it was more comfortable and the increase in RR and dyspnea seen with SO did not occur with HFNT. Therefore, HFNT could be a suitable alternative to SO during breaks off NIV.

摘要

目的

评估高流量鼻导管氧疗(HFNT)与标准氧疗(SO)作为补充治疗非侵入性通气(NIV)的作用。

方法

这是一项多中心试验,纳入了预计需要接受 NIV 治疗≥24 小时的患者(n=54),这些患者因急性或急性加重期慢性呼吸衰竭而接受治疗。患者被随机分为 SO 组或 HFNT 组,在 NIV 暂停期间接受相应治疗。主要结局为总 NIV 使用时间和脱机时间。次要结局为舒适度和呼吸困难、呼吸频率(RR)、氧饱和度(SO)、耐受性和不良反应。

结果

HFNT 组和 SO 组患者的 NIV 总使用时间(1315 分钟比 1441 分钟)和 NIV 暂停时间(1362 分钟比 1196 分钟)相似,且每次 NIV 暂停的平均持续时间(520 分钟比 370 分钟)也相似(p>.05)。HFNT 组的舒适度评分高于 SO 组(8.3±2.7 比 6.9±2.3,p=0.001)。HFNT 组和 SO 组的 RR 和 SO 相似,但在 SO 组,NIV 暂停期间 RR 和呼吸困难增加,而 HFNT 组并未发生这种情况。

结论

与 SO 相比,HFNT 并未减少 NIV 使用时间。然而,HFNT 更舒适,并且在 NIV 暂停期间,SO 引起的 RR 和呼吸困难增加的情况并未在 HFNT 组发生。因此,HFNT 可能是 NIV 暂停期间替代 SO 的一种合适选择。

相似文献

1
High-flow nasal therapy vs standard oxygen during breaks off noninvasive ventilation for acute respiratory failure: A pilot randomized controlled trial.高流量鼻导管通气与标准氧疗在急性呼吸衰竭无创通气间歇期的应用比较:一项前瞻性随机对照试验
J Crit Care. 2018 Dec;48:418-425. doi: 10.1016/j.jcrc.2018.10.004. Epub 2018 Oct 5.
2
High-flow nasal therapy versus noninvasive ventilation in COPD patients with mild-to-moderate hypercapnic acute respiratory failure: study protocol for a noninferiority randomized clinical trial.高流量鼻导管通气与无创通气治疗 COPD 合并轻中度高碳酸血症急性呼吸衰竭患者的随机对照非劣效性临床试验方案。
Trials. 2019 Jul 22;20(1):450. doi: 10.1186/s13063-019-3514-1.
3
High flow nasal therapy versus noninvasive ventilation as initial ventilatory strategy in COPD exacerbation: a multicenter non-inferiority randomized trial.高流量鼻导管通气与无创通气在 COPD 加重期作为初始通气策略的比较:一项多中心非劣效性随机试验。
Crit Care. 2020 Dec 14;24(1):692. doi: 10.1186/s13054-020-03409-0.
4
Sequential application of oxygen therapy via high-flow nasal cannula and noninvasive ventilation in acute respiratory failure: an observational pilot study.高流量鼻导管给氧与无创通气序贯应用于急性呼吸衰竭的观察性初步研究。
Respir Care. 2015 Feb;60(2):170-8. doi: 10.4187/respcare.03075. Epub 2014 Oct 7.
5
Nasal high-flow oxygen therapy in patients with hypoxic respiratory failure: effect on functional and subjective respiratory parameters compared to conventional oxygen therapy and non-invasive ventilation (NIV).低氧性呼吸衰竭患者的经鼻高流量氧疗:与传统氧疗和无创通气(NIV)相比,对功能和主观呼吸参数的影响
BMC Anesthesiol. 2014 Aug 7;14:66. doi: 10.1186/1471-2253-14-66. eCollection 2014.
6
High-Flow Nasal Cannula Therapy Versus Intermittent Noninvasive Ventilation in Obese Subjects After Cardiothoracic Surgery.心胸外科手术后肥胖患者的高流量鼻导管吸氧疗法与间歇性无创通气比较
Respir Care. 2017 Sep;62(9):1193-1202. doi: 10.4187/respcare.05473. Epub 2017 Aug 14.
7
Effect of Postextubation High-Flow Nasal Cannula vs Noninvasive Ventilation on Reintubation and Postextubation Respiratory Failure in High-Risk Patients: A Randomized Clinical Trial.高风险患者拔管后使用高流量鼻导管与无创通气对再插管和拔管后呼吸衰竭的影响:一项随机临床试验。
JAMA. 2016 Oct 18;316(15):1565-1574. doi: 10.1001/jama.2016.14194.
8
High flow nasal oxygen for acute type two respiratory failure: a systematic review.高流量鼻氧疗治疗急性 II 型呼吸衰竭:系统评价。
F1000Res. 2021 Jun 16;10:482. doi: 10.12688/f1000research.52885.2. eCollection 2021.
9
Comparison of high-flow nasal oxygen therapy with conventional oxygen therapy and noninvasive ventilation in adult patients with acute hypoxemic respiratory failure: A meta-analysis and systematic review.高流量鼻导管给氧疗法与传统氧疗及无创通气治疗成年急性低氧性呼吸衰竭患者的比较:一项荟萃分析和系统评价
J Crit Care. 2016 Oct;35:138-44. doi: 10.1016/j.jcrc.2016.05.013. Epub 2016 May 25.
10
High-flow nasal cannula oxygen versus noninvasive ventilation for the management of acute cardiogenic pulmonary edema: a randomized controlled pilot study.高流量鼻导管吸氧与无创通气治疗急性心源性肺水肿的随机对照初步研究。
Eur J Emerg Med. 2024 Aug 1;31(4):267-275. doi: 10.1097/MEJ.0000000000001128. Epub 2024 Feb 16.

引用本文的文献

1
High-flow nasal oxygen therapy compared with conventional oxygen therapy in hospitalised patients with respiratory illness: a systematic review and meta-analysis.高流量鼻氧疗与常规氧疗在住院呼吸系统疾病患者中的比较:系统评价和荟萃分析。
BMJ Open Respir Res. 2024 Jul 15;11(1):e002342. doi: 10.1136/bmjresp-2024-002342.
2
Effect of high-flow nasal cannula at different flow rates on diaphragmatic function in subjects recovering from an acute exacerbation of COPD: a physiological prospective pilot study.不同流速的高流量鼻导管对慢性阻塞性肺疾病急性加重期恢复患者膈肌功能的影响:一项生理学前瞻性初步研究。
J Anesth Analg Crit Care. 2024 Jun 24;4(1):37. doi: 10.1186/s44158-024-00173-3.
3
Bronchodilator Efficacy of High-Flow Nasal Cannula in COPD: Vibrating Mesh Nebulizer Versus Jet Nebulizer.
高流量鼻导管在 COPD 中的支气管扩张剂疗效:振动网式雾化器与射流雾化器比较。
Respir Care. 2024 Jan 24;69(2):157-165. doi: 10.4187/respcare.11139.
4
Respiratory Care Management of COPD Exacerbations.慢性阻塞性肺疾病急性加重的呼吸治疗管理。
Respir Care. 2023 Jun;68(6):821-837. doi: 10.4187/respcare.11069.
5
The use of High-Flow Nasal Oxygen Therapy in 4 dogs undergoing bronchoscopy.对4只接受支气管镜检查的犬使用高流量鼻导管给氧疗法。
Front Vet Sci. 2023 Mar 30;10:1088103. doi: 10.3389/fvets.2023.1088103. eCollection 2023.
6
Home High-Flow Therapy in Patients with Chronic Respiratory Diseases: Physiological Rationale and Clinical Results.慢性呼吸道疾病患者的家庭高流量治疗:生理原理与临床结果
J Clin Med. 2023 Apr 3;12(7):2663. doi: 10.3390/jcm12072663.
7
Recent advances in critical care: Part II.重症监护的最新进展:第二部分。
Indian J Anaesth. 2023 Jan;67(1):110-116. doi: 10.4103/ija.ija_1006_22. Epub 2023 Jan 21.
8
Clinical review of high-flow nasal oxygen therapy in human and veterinary patients.人医和兽医患者高流量鼻导管给氧疗法的临床综述
Front Vet Sci. 2023 Mar 6;10:1070881. doi: 10.3389/fvets.2023.1070881. eCollection 2023.
9
Highlights from the Respiratory Failure and Mechanical Ventilation 2022 Conference.2022年呼吸衰竭与机械通气会议亮点
ERJ Open Res. 2023 Mar 20;9(2). doi: 10.1183/23120541.00467-2022. eCollection 2023 Mar.
10
High-flow nasal oxygen in acute hypoxemic respiratory failure: A narrative review of the evidence before and after the COVID-19 pandemic.急性低氧性呼吸衰竭中的高流量鼻导管给氧:COVID-19大流行前后证据的叙述性综述
Front Med (Lausanne). 2022 Nov 25;9:1068327. doi: 10.3389/fmed.2022.1068327. eCollection 2022.